[ad_1]
My Legacy Advisors LLC trimmed its place in Johnson & Johnson (NYSE:JNJ – Free Report) by 44.4% within the third quarter, in accordance with its most up-to-date 13F submitting with the Securities and Trade Fee. The agency owned 2,155 shares of the corporate’s inventory after promoting 1,721 shares in the course of the quarter. My Legacy Advisors LLC’s holdings in Johnson & Johnson have been value $328,000 on the finish of the latest reporting interval.
A number of different institutional traders have additionally just lately made modifications to their positions within the firm. Impartial Advisor Alliance lifted its holdings in Johnson & Johnson by 0.9% in the course of the second quarter. Impartial Advisor Alliance now owns 153,337 shares of the corporate’s inventory value $25,380,000 after shopping for a further 1,327 shares in the course of the interval. Franklin Road Advisors Inc. NC lifted its stake in shares of Johnson & Johnson by 0.7% in the course of the 2nd quarter. Franklin Road Advisors Inc. NC now owns 80,179 shares of the corporate’s inventory value $13,271,000 after buying a further 562 shares over the past quarter. Cypress Wealth Providers LLC grew its stake in Johnson & Johnson by 5.4% within the second quarter. Cypress Wealth Providers LLC now owns 9,725 shares of the corporate’s inventory valued at $1,547,000 after buying a further 497 shares over the past quarter. King Luther Capital Administration Corp lifted its place in shares of Johnson & Johnson by 0.3% in the course of the second quarter. King Luther Capital Administration Corp now owns 643,435 shares of the corporate’s inventory valued at $106,501,000 after shopping for a further 2,027 shares over the past quarter. Lastly, Moseley Funding Administration Inc. boosted its holdings in shares of Johnson & Johnson by 5.3% within the 2nd quarter. Moseley Funding Administration Inc. now owns 17,163 shares of the corporate’s inventory valued at $2,841,000 after shopping for a further 857 shares within the final quarter. Hedge funds and different institutional traders personal 68.40% of the corporate’s inventory.
Johnson & Johnson Buying and selling Up 0.3 %
Johnson & Johnson inventory opened at $161.13 on Friday. The corporate has a present ratio of 1.21, a fast ratio of 0.96 and a debt-to-equity ratio of 0.37. The agency has a market cap of $387.88 billion, a PE ratio of 11.96, a P/E/G ratio of three.08 and a beta of 0.53. The inventory’s 50 day easy shifting common is $153.57 and its two-hundred day easy shifting common is $159.44. Johnson & Johnson has a 12 month low of $144.95 and a 12 month excessive of $180.93.
Johnson & Johnson (NYSE:JNJ – Get Free Report) final launched its quarterly earnings outcomes on Tuesday, October seventeenth. The corporate reported $2.66 EPS for the quarter, beating the consensus estimate of $2.52 by $0.14. The corporate had income of $21.35 billion for the quarter, in comparison with analyst estimates of $21 billion. Johnson & Johnson had a internet margin of 36.32% and a return on fairness of 37.14%. Analysts anticipate that Johnson & Johnson will put up 9.96 earnings per share for the present yr.
Johnson & Johnson Broadcasts Dividend
The agency additionally just lately declared a quarterly dividend, which can be paid on Tuesday, March fifth. Shareholders of report on Tuesday, February twentieth can be given a dividend of $1.19 per share. The ex-dividend date of this dividend is Friday, February sixteenth. This represents a $4.76 dividend on an annualized foundation and a yield of two.95%. Johnson & Johnson’s dividend payout ratio is presently 35.34%.
Wall Road Analyst Weigh In
Various equities analysis analysts just lately commented on JNJ shares. StockNews.com reduce shares of Johnson & Johnson from a “strong-buy” score to a “purchase” score in a analysis report on Monday, January 1st. Wells Fargo & Firm reduce Johnson & Johnson from an “chubby” score to an “equal weight” score and lowered their value goal for the inventory from $170.00 to $163.00 in a analysis report on Wednesday, December thirteenth. Raymond James upped their goal value on Johnson & Johnson from $172.00 to $175.00 and gave the corporate an “outperform” score in a analysis report on Wednesday. TheStreet lowered Johnson & Johnson from a “b” score to a “c+” score in a analysis notice on Friday, November seventeenth. Lastly, Cantor Fitzgerald reaffirmed an “chubby” score on shares of Johnson & Johnson in a analysis report on Monday, December 18th. Eight analysts have rated the inventory with a maintain score and 7 have issued a purchase score to the inventory. In response to information from MarketBeat, the corporate has a consensus score of “Maintain” and a median value goal of $168.94.
View Our Newest Inventory Evaluation on Johnson & Johnson
About Johnson & Johnson
(Free Report)
Johnson & Johnson, along with its subsidiaries, researches, develops, manufactures, and sells numerous merchandise within the healthcare subject worldwide. The corporate’s Shopper Well being phase gives pores and skin well being/magnificence merchandise beneath the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise beneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise beneath the LISTERINE model; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and allergy merchandise; BENADRYL and ZYRTEC allergy merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disorder merchandise.
See Additionally
Need to see what different hedge funds are holding JNJ? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).
Obtain Information & Rankings for Johnson & Johnson Each day – Enter your e-mail deal with beneath to obtain a concise each day abstract of the most recent information and analysts’ rankings for Johnson & Johnson and associated corporations with MarketBeat.com’s FREE each day e-mail e-newsletter.
[ad_2]
Source link